NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
about
RASopathies: unraveling mechanisms with animal modelsMoyamoya Syndrome: A Window of Moyamoya DiseaseSmall G proteins in the cardiovascular system: physiological and pathological aspectsLoss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis.Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferationGiant extracranial aneurysm of the internal carotid artery in neurofibromatosis type 1. A case report and review of the literature.Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β.Neurofibromin regulates somatic growth through the hypothalamic-pituitary axisDemethylation treatment restores erectile function in a rat model of hyperhomocysteinemiaMAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.Mice lacking neurofibromin develop gastric hyperplasia.Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy.The ecology of brain tumors: lessons learned from neurofibromatosis-1.Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.Cerebral vasculopathy in a Chinese family with neurofibromatosis type I mutation.Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.A case report of acute myeloid leukemia and neurofibromatosis 1.Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension.Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.
P2860
Q26800379-350FBCF1-3344-428F-8936-9346DE5EA893Q26800801-CA3A8D9C-309E-4E84-9733-CD5C38F8BD45Q27010607-46DFCB69-DF62-443C-963B-3CA0E3BE56A8Q29347536-1F991773-A1F6-403E-A4E1-38418A2CE66FQ30493459-377EF2EF-F30A-42F0-B515-DF64CD862D76Q30706016-B2796E40-B22C-4F48-A277-6C00F827FEC2Q33685670-D9055AE0-E61B-439D-B3F5-230D17789FE9Q33831164-9DEA8BC6-E3C9-4DD1-8974-E662C3FBB50BQ34474278-0FCC0B3A-A4AA-4905-96CD-7BF74FF0E2F7Q35944775-7E54C3DA-C5C8-4353-A8F0-23FA22FC1220Q36234116-249F5A04-239C-4C08-B96D-1D65B2AC46D3Q36395077-8FE66F3E-70A3-4CF4-87FB-0B17588145DFQ36425828-2DDBA749-B76D-4F56-B700-B10DF267840BQ36975163-4D4AE6D9-24FD-4F87-B45B-4C0AC01C78D8Q37001127-99FFC4C4-88C7-41C0-BA09-C767BC8E9B35Q37210355-DFE77B7B-711A-41CF-B6C7-97AB73A11FBBQ37254485-A68C9A74-BD0E-471F-B764-5C7874D2A989Q37353815-D4F12C97-BBF0-4451-9EE3-4F60C271C316Q37391841-56FD74A6-ED6F-4106-8E72-5F21A081E827Q37649834-77989A71-606B-41A5-AC1C-A9BA7C2C3E8CQ37687053-EF0FC47F-4E19-4B73-B6A7-17F5735BC616Q37809458-F5C35AD4-0871-4171-B60A-7B3546558857Q38694212-9F889029-DE08-4C09-B502-D65CD363CCA6Q40149491-D5DD77E2-6FA8-4793-9D70-58E475ED9322Q40237430-278467B4-DF27-435B-8A93-CB06EF65DA60Q41637594-5757262A-156E-44F7-8320-F6CF8CA896D2Q42538041-4FCB4FE0-D54C-43D0-8F4E-A3689C8C4574Q43080898-46C67387-C906-48EA-B14B-A981F80ED309Q52098195-75F6B9E3-B268-45C1-9859-EDA9ED2D118FQ54493295-D6EAD6AE-B9D4-4BCA-9D8C-9242639B9D89Q55431130-E382A851-1850-4F65-8BE1-7FA7A52CFD64
P2860
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@en
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@nl
type
label
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@en
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@nl
prefLabel
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@en
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@nl
P2093
P1433
P1476
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
@en
P2093
Fraz A Ismat
Jonathan A Epstein
Junwang Xu
P304
P356
10.1161/CIRCULATIONAHA.107.707752
P407
P577
2007-10-22T00:00:00Z